Gait Speed for Predicting Cardiovascular Events After Myocardial Infarction
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01484158|
Recruitment Status : Completed
First Posted : December 2, 2011
Last Update Posted : January 22, 2015
Yokohama City University Medical Center
Information provided by (Responsible Party):
Yasushi Matsuzawa, Yokohama City University Medical Center
There are growing evidences that gait speed is inversely associated with all causes mortality especially cardiovascular mortality among the elderly. The purpose of this study is to evaluate the predictive value of gait speed for cardiovascular events in patients after ST-segment elevation myocardial infarction (STEMI).
|Condition or disease|
The investigators will enroll patients capable of walking with STEMI. All patients will receive successful reperfusion therapy within 12-hour from onset. Gait speed during cardiac rehabilitation is measured. Cardiovascular events were defined as a composite of cardiovascular death, non-fatal myocardial infarction and non-fatal stroke, for an average follow-up period.
|Study Type :||Observational|
|Actual Enrollment :||450 participants|
|Official Title:||Gait Speed for Predicting Cardiovascular Events After Myocardial Infarction|
|Study Start Date :||October 2001|
|Actual Primary Completion Date :||December 2012|
|Actual Study Completion Date :||December 2012|
Patients with myocardial infarction
Primary Outcome Measures :
- Cardiovascular Events [ Time Frame: 5 years ]cardiovascular death, non-fatal myocardial infarction and non-fatal stroke
Biospecimen Retention: Samples Without DNA
We retain only blood sample only in this study.
No Contacts or Locations Provided